It has been reported that the activation or overexpression of PKC-α is associated with cardiac hypertrophy, mitogenic stimulation, dilated cardiac myopathy, ischemic injury, myocardial infarction, and human heart failure (13–15). Here, PRKCA is linked to heart failure.